# Modelle 001, TS-inhibition in Colorectal Liver Metastases Comparing Arfolitixorin and Calciumfolinate

> **NCT04126655** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Vastra Gotaland Region** · enrollment: 30 (estimated)

## Conditions studied

- Metastatic Colorectal Cancer

## Interventions

- **DRUG:** Arfolitixorin

## Key facts

- **NCT ID:** NCT04126655
- **Lead sponsor:** Vastra Gotaland Region
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-02-05
- **Primary completion:** 2021-10
- **Final completion:** 2021-11
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2020-08-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04126655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04126655, "Modelle 001, TS-inhibition in Colorectal Liver Metastases Comparing Arfolitixorin and Calciumfolinate". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04126655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*